MedWatch

Novo Ventures launches a number of pharmaceuticals and medical equipment

During 2011 the invest company Novo Ventures was more active than ever, and since the company was founded and began making its first investments 11 years ago it has helped launch 13 new products. Through a number of exits the company has managed to meet its target of a 15-20 % return.

Foto: PR/Dansk Biotek

From the ”Novo family”, it is not just Novo Nordisk and Novozymes that have managed to achieve great commercial success on the global life science market – far from it. Since the company was founded in 2000, Novo Ventures has invested about DKK 4 billion in 75 different companies worldwide. Of these companies just about 40 belong to the company’s active portfolio, while approximately 35 have been sold off, gone public or have been liquidated.

The information is provided by managing partner Søren Carlsen of Novo Ventures and Novo Seeds, which are both parts of Novo A/S. Novo A/S, which has majority control of both Novo Nordisk and Novozymes, is owned entirely by The Novo Nordisk Foundation.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier